Clover Biopharmaceuticals partners up with GSK to accelerate coronavirus vaccine development
February 24, 2020Sales and Marketing China, Clover Biopharmaceuticals, GSK, coronavirus, pharma
Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …
Eli Lilly’s Trulicity approved in US to reduce cardiovascular events in type 2 diabetes patients
February 24, 2020Sales and Marketing Eli Lilly, Trulicity, cardiovascular disease, pharma
Eli Lilly’s Trulicity (duraglutide) has been awarded marketing authorisation from the FDA as a therapy to reduce major adverse cardiovascular …
Lundbeck’s Vyepti secures US approval for migraine prevention
February 24, 2020Sales and Marketing FDA, Lundbeck, Vyepti, migraine, pharma
Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention of migraine in adult patients. …
FDA approval for Baudax Bio’s non-opioid painkiller Anjeso
February 24, 2020Sales and Marketing Anjeso, FDA, opioids, pharma
Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …
Merck KGaA to flog Allergopharma business to Dermapharm
February 21, 2020Medical Communications, Sales and Marketing Allergopharma, Dermapharm, Merck KGaA, pharma
German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …
Teva’s Austedo fails in two paediatric Tourette’s syndrome trials
February 21, 2020Medical Communications, Research and Development Austedo, Teva, pharma, tourette's
Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …
Top Ten most popular articles on Pharmafile.com this week
February 21, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids
The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …
Ukrainian protestors attack bus carrying Chinese evacuees from Wuhan
February 21, 2020Medical Communications Chinese Coronavirus, MERS, Sars, Wuhan, Wuhan Coronavirus, coronavirus
On Thursday, Ukrainian protestors attacked buses carrying people evacuated from Wuhan in China, the epicenter of the coronavirus outbreak. The …
New antibiotic discovered by AI for the first time
February 21, 2020Medical Communications AI, AI Clinical Trials, AI Drugs, AI antibiotics, MIT, algorithm, clinical trials
MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …
New Keytruda dosing schedule rejected in six cancers by the FDA
February 20, 2020Sales and Marketing Cancer, FDA, MSD, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …
Bristol-Myers Squibb demonstrates potential for long-term survival in kidney cancer patients treated with Opdivo plus Yervoy
February 20, 2020Business Services Cancer, Cancers, Yervoy, opdivo, renacl cell carcinoma, renal cancer
Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …
GlaxoSmithKline acquires two solid tumor cell therapies from Immatics for $50 million
February 20, 2020Business Services Cancer, cancer cells, celluar immunotherapies, immunotherapies
GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …
FDA approved over 1,000 generic drugs in 2019
February 20, 2020Research and Development, Sales and Marketing FDA, generic drugs, pharma
The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …
Two passengers with coronavirus die on quarantined cruise ship in Japan
February 20, 2020Business Services Chinese Coronavirus, MARS, Sars, Wuhan, Wuhan Coronavirus, coronavirus
Two Japanese passengers on a quarantined cruise ship have died after contracting the coronavirus.The pair were both in their 80’s …
Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel
February 19, 2020Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis
The European Commission (EC) has awarded marketing approval to Pfizer’s Vyndaqel (tafamidis), it has emerged, for the treatment of wild-type …
CEO of PixarBio Corporation sentenced to prison for defrauding investors
February 19, 2020Research and Development Biopharmaceuticals, CEO, FDA, corruption, fraud, investors
Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in prison for defrauding investors and …
FDA teams up with Indian government to crack down on illicit drugs shipments
February 19, 2020Research and Development FDA, FDA India, FDA trade, Indian Pharma
The FDA announced yesterday its first successful bilateral enforcement operation with the Government of India, where they stopped 500 shipments …
Opdivo + cabiralizumab combo falls flat in advanced pancreatic cancer
February 19, 2020Research and Development Bristol-Myers Squibb, Five Prime Therapeutics, Pancreatic cancer, cabiralizumab, opdivo, pharma
Five Prime Therapeutics and Bristol-Myers Squibb have confirmed that their randomised Phase 2 trial investigating the efficacy of the former’s …
Women who take statins could be less likely to develop ovarian cancer, study finds
February 19, 2020Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins
A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …
Janssen shows off Phase 3b interim data for Stelara in Crohn’s disease
February 18, 2020Manufacturing and Production, Research and Development Crohn’s disease, Janssen, Stelara, crohn's disease, pharma
Janssen has revealed new interim Phase 3b data from a study investigating the efficacy of Stelara (ustekinumab) in the treatment …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
